Titre:
  • Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours
Auteur:Jones, Robin Lewis; Ratain, Mark M.J.; O'Dwyer, Peter P.J.; Siu, Lillian L; Jassem, Jacek; Medioni, Jacques; DeJonge, Maja; Rudin, Charles; Sawyer, Michael M.B.; Khayat, David; Awada, Ahmad; de Vos-Geelen, Judith J.M.P.G.M.; Evans, Thomas Ronald Jeffrey; Obel, Jennifer; Brockstein, Bruce; DeGreve, Jacques; Baurain, Jean-Francois; Maki, Robert; D'Adamo, David; Dickson, Mark; Undevia, Samir; Geary, David; Janisch, Linda; Bedard, Philippe L; Abdul Razak, Albiruni Ryan; Kristeleit, Rebecca; Vitfell-Rasmussen, Joanna; Walters, Ian; Kaye, Stan S.B.; Schwartz, Gary
Informations sur la publication:European journal of cancer, 120, page (132-139)
Statut de publication:Publié, 2019-10
Sujet CREF:Cancérologie
Mots-clés:Brivanib
FGF2 status
Ovarian cancer
Randomised discontinuation trial
Sarcomas
Solid tumours
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2019.07.024
info:pii/S0959804919304435
info:scp/85072047537
info:pmid/31522033